Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00585390 · ClinicalTrials.gov registry record · Phase 2
Omega-3 Fatty Acid Deficiency Replacement in Early Schizophrenia
A Phase 2 study, sponsored by University of Cincinnati.
- Completed
- Registry status
- Phase 2
- Development phase
NCT00585390 is a Phase 2 study that has completed, run by University of Cincinnati.
The verdict
NCT00585390, a Phase 2 study, has completed, sponsored by University of Cincinnati.
- COMPLETED
- Registry status
- Phase 2
- Development phase
Study Summary
The purpose of this research study is to find out what effects (good and bad) that omega-3 fatty acids has on schizophrenia.
Interventions
- DRUG Placebo
- DIETARY_SUPPLEMENT Omega-3 Fatty Acids
- OTHER Olive oil placebo
- DIETARY_SUPPLEMENT EPA fish oil concentrate; DHA fish oil concentrate
Trial Details
| Field | Value |
|---|---|
| Start Date | 2008-01 |
| Est. Completion | 2009-11 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00585390
The ClinicalTrials.gov registry entry for NCT00585390 describes a study currently listed as completed, categorized as Phase 2. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is University of Cincinnati, which has 245 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Placebo is the first listed.
NCT00585390 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00585390 about?
NCT00585390 is a clinical study titled "Omega-3 Fatty Acid Deficiency Replacement in Early Schizophrenia". The purpose of this research study is to find out what effects (good and bad) that omega-3 fatty acids has on schizophrenia.
What is the current status of trial NCT00585390?
This trial is currently completed. It is a Phase 2 study. The study started on 2008-01. Estimated completion is 2009-11.
What interventions are being tested in trial NCT00585390?
The interventions under investigation include: Placebo (DRUG), Omega-3 Fatty Acids (DIETARY_SUPPLEMENT), Olive oil placebo (OTHER), EPA fish oil concentrate; DHA fish oil concentrate (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00585390?
This trial is sponsored by University of Cincinnati, which has 245 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.